SEC Comment Letter for AIM ImmunoTech Inc. (AIM) (CIK 0000946644) (AIM) — Aug 12, 2008

AIM ImmunoTech Inc. (AIM) (CIK 0000946644)
Date: Aug. 12, 2008 · CIK: 0000946644 · Accession: 0000000000-08-040657

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

July 25, 2008

Author

Jeffrey P. Riedler

Form

UPLOAD

Company

AIM ImmunoTech Inc. (AIM) (CIK 0000946644)

Letter

Mail Stop 6010 July 25, 2008 William A. Carter, M.D. Chief Executive Officer Hemispherx Biopharma, Inc. 1617 JFK Boulevard Philadelphia, Pennsylvania 19103 Re: Hemispherx Biopharma, Inc. Schedule 14A Filed July 16, 2008 File No. 1-13441

Dear Dr. Carter:

We have completed our review of your preliminary proxy statement on Schedule 14A and have no further comments at this time.

Sincerely,
J e f f r e y P . R i e d l e r A s s i s t a n t D i r e c t o r

Show Raw Text

Mail Stop 6010                                                                                                   July 25, 2008     William A. Carter, M.D. Chief Executive Officer Hemispherx Biopharma, Inc. 1617 JFK Boulevard Philadelphia, Pennsylvania 19103
 Re: Hemispherx Biopharma, Inc.
  Schedule 14A   Filed July 16, 2008   File No. 1-13441

Dear Dr. Carter:

 We have completed our review of  your preliminary proxy statement on
Schedule 14A and have no further comments at this time.

Sincerely,
           J e f f r e y  P .  R i e d l e r          A s s i s t a n t  D i r e c t o r

SecProbe.io